Carbidopa and Levodopa Extended-Release Tablets and Natalizumab Intravenous
Determining the interaction of Carbidopa and Levodopa Extended-Release Tablets and Natalizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: natalizumab
Brand name: Tysabri
Synonyms: Natalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and Levodopa Extended-Release Tablets-Natalvirt 90 DHA
- Carbidopa and Levodopa Extended-Release Tablets-Natalvirt CA
- Carbidopa and Levodopa Extended-Release Tablets-Natazia
- Carbidopa and Levodopa Extended-Release Tablets-Nateglinide
- Carbidopa and Levodopa Extended-Release Tablets-Natelle Complete
- Carbidopa and Levodopa Extended-Release Tablets-Natelle One
- Natalizumab Intravenous-Carbidopa and Levodopa ODT
- Natalizumab Intravenous-Carbidopa and Levodopa Orally Disintegrating Tablets
- Natalizumab Intravenous-Carbidopa and levodopa Route Not Applicable
- Natalizumab Intravenous-Carbidopa and Levodopa Tablets
- Natalizumab Intravenous-Carbidopa Tablets
- Natalizumab Intravenous-Carbidopa, entacapone, and levodopa